Two studies suggest that T cells with stem-cell-like properties could work with antibody therapies to control HIV after a ...

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...

HANGZHOU, China and SHANGHAI and BOSTON, Dec. 2, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), ...

Type 1 diabetes (T1D) is an autoimmune disorder characterized by the specific destruction of insulin-producing pancreatic β-cells. While islet ...

EpCAM-targeted immunotherapies present opportunities in cancer treatment, notably adenocarcinomas, due to high expression in epithelial tumors. Innovations such as conditional activation could ...

The IL-6 receptor antagonist market presents significant opportunities in underexplored areas like thyroid eye disease and atherosclerotic cardiovascular disease (ASCVD). Recent acquisitions and ...

Two teams discover how small cell lung cancer hijacks neural pathways to proliferate faster, especially to the brain. Common ...

Groundbreaking brain atlases reveal dynamic neuron and glia development across species, transforming static maps into a ...

PN-943 (IBD Program) -- Oral, gut-restricted alpha-4-beta-7 integrin antagonist demonstrated greater than threefold improved ...

Advancements in transplantation are inseparable from progress in immunomodulatory treatments. Since 1902, the advent of ...

Skin regeneration: Though less directly tied to rhinitis, external nasal defects from surgery or chronic inflammation can be ...

The OT-I mouse T-cell receptor (TCR) is thought to perfectly discriminate between lower-affinity self- and higher-affinity ...